Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 637 Shares

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 637 shares of Omada Health stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $23.00, for a total transaction of $14,651.00. Following the completion of the transaction, the chief accounting officer directly owned 15,441 shares in the company, valued at approximately $355,143. The trade was a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The shares were sold at an average price of $22.00, for a total transaction of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The stock was sold at an average price of $20.00, for a total transaction of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Performance

NASDAQ:OMDA opened at $22.39 on Friday. The company has a market cap of $1.33 billion and a PE ratio of -82.93. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The stock has a 50-day simple moving average of $17.16 and a 200 day simple moving average of $15.03.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. On average, research analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Quarry LP acquired a new position in shares of Omada Health in the fourth quarter valued at about $29,000. TD Waterhouse Canada Inc. bought a new position in shares of Omada Health during the fourth quarter worth approximately $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the second quarter valued at approximately $32,000. Inlight Wealth Management LLC acquired a new stake in Omada Health during the fourth quarter worth about $45,000. Finally, Versant Capital Management Inc increased its holdings in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after buying an additional 2,283 shares during the period.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on OMDA shares. Canaccord Genuity Group set a $24.00 target price on Omada Health in a report on Friday, May 8th. Morgan Stanley reiterated an “overweight” rating and set a $30.00 price objective on shares of Omada Health in a research note on Monday, June 22nd. JPMorgan Chase & Co. cut their price objective on Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a report on Thursday, March 12th. Barclays boosted their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Finally, Citizens Jmp boosted their price objective on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.